2024-10-21 23:09:53
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research
Health/ 2023-07-22
GenFleet Announces First Patient Dosed i...

PERTH,Australia and TAIPEI and SHANGHAI,Oct. 21,2021-- GenFleet Therapeutics,a clinical-stage biotechnology company focusing on cutting-edge...

EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization
Health/ 2023-07-22
EVERSANA and Intouch Group join forces, ...

CHICAGO and KANSAS CITY,Mo.,Oct. 20,2021-- EVERSANA™,the pioneer of next generation commercial services to the global life sciences industr...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release